455 related articles for article (PubMed ID: 24996516)
1. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
Gabriel L; Beriot-Mathiot A
J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516
[TBL] [Abstract][Full Text] [Related]
2. Attributable Cost of Clostridium difficile Infection in Pediatric Patients.
Mehrotra P; Jang J; Gidengil C; Sandora TJ
Infect Control Hosp Epidemiol; 2017 Dec; 38(12):1472-1477. PubMed ID: 29173236
[TBL] [Abstract][Full Text] [Related]
3. Attributable costs and length of stay of hospital-acquired
Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P
Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884
[TBL] [Abstract][Full Text] [Related]
4. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T
Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805
[TBL] [Abstract][Full Text] [Related]
5. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.
Tabak YP; Zilberberg MD; Johannes RS; Sun X; McDonald LC
Infect Control Hosp Epidemiol; 2013 Jun; 34(6):588-96. PubMed ID: 23651889
[TBL] [Abstract][Full Text] [Related]
6. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.
Mollard S; Lurienne L; Heimann SM; Bandinelli PA
J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.
Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F
J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542
[TBL] [Abstract][Full Text] [Related]
8. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE
Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438
[TBL] [Abstract][Full Text] [Related]
9. The economic burden of Clostridium difficile.
McGlone SM; Bailey RR; Zimmer SM; Popovich MJ; Tian Y; Ufberg P; Muder RR; Lee BY
Clin Microbiol Infect; 2012 Mar; 18(3):282-9. PubMed ID: 21668576
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.
Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW
J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056
[TBL] [Abstract][Full Text] [Related]
11. The burden of Clostridium difficile in surgical patients in the United States.
Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT
Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection.
Wiegand PN; Nathwani D; Wilcox MH; Stephens J; Shelbaya A; Haider S
J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638
[TBL] [Abstract][Full Text] [Related]
13. Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults.
Chen Y; Glass K; Liu B; Korda RJ; Riley TV; Kirk MD
Am J Infect Control; 2017 May; 45(5):508-511. PubMed ID: 28089675
[TBL] [Abstract][Full Text] [Related]
14. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F;
J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518
[TBL] [Abstract][Full Text] [Related]
15. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre.
van Beurden YH; Bomers MK; van der Werff SD; Pompe EAPM; Spiering S; Vandenbroucke-Grauls CMJE; Mulder CJJ
J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
Rodrigues R; Barber GE; Ananthakrishnan AN
Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
[TBL] [Abstract][Full Text] [Related]
18. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
[TBL] [Abstract][Full Text] [Related]
19. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
Fukuda H; Yano T; Shimono N
Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
[TBL] [Abstract][Full Text] [Related]
20. The prolongation of length of stay because of Clostridium difficile infection.
Mitchell BG; Gardner A; Barnett AG; Hiller JE; Graves N
Am J Infect Control; 2014 Feb; 42(2):164-7. PubMed ID: 24290226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
